Gynecologic Cancer News

The addition of AK104 to concurrent chemoradiotherapy improved survival outcomes for patients with locally advanced cervical cancer, according to data presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.

Clinicians should adopt a risk-based, rather than biopsy-first, approach to encourage biopsy acceptance and improve early diagnosis of endometrial cancer among Black women, according to researchers.

An AI-based cancer prediction system is designed to ensure a higher percentage of cancers are diagnosed at earlier, more treatable stages.

A clinician nudge for referral to a gynecologic oncologist at the time of suspected ovarian cancer diagnosis improved referral rates by 20 percentage points, according to study results.

The addition of glucagon-like peptide-1 receptor agonists to progestin therapy may help reduce endometrial cancer risk among certain women, according to study results.

Healio is pleased to announce its partnership with CancerX, a public-private collaboration dedicated to the acceleration of innovation in cancer treatment.

Newborns with congenital heart disease and their mothers may both face elevated risk for cancer compared with their counterparts not affected by congenital heart disease, according to study findings in Circulation.

PD-1 blockade conferred benefit to certain women with surgically resectable endometrial cancer, findings presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer showed.

A novel two-drug combination exhibited antitumor activity among certain women with advanced endometrial cancer, data presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer showed.